Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,184 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical experience with the Palmaz-Schatz coronary stent.
Schatz RA, Goldberg S, Leon M, Baim D, Hirshfeld J, Cleman M, Ellis S, Topol E. Schatz RA, et al. J Am Coll Cardiol. 1991 May;17(6 Suppl B):155B-159B. doi: 10.1016/0735-1097(91)90952-6. J Am Coll Cardiol. 1991. PMID: 2016473 Free article. Clinical Trial.
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Roe MT, et al. Among authors: topol ej. Eur Heart J. 2004 Feb;25(4):313-21. doi: 10.1016/j.ehj.2003.12.009. Eur Heart J. 2004. PMID: 14984920 Free article. Clinical Trial.
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
Newby LK, Bhapkar MV, White HD, Topol EJ, Dougherty FC, Harrington RA, Smith MC, Asarch LF, Califf RM; SYMPHONY and 2nd SYMPHONY Investigators. Newby LK, et al. Among authors: topol ej. Eur Heart J. 2003 Jan;24(2):172-81. doi: 10.1016/s0195-668x(02)00325-1. Eur Heart J. 2003. PMID: 12573274 Clinical Trial.
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe MT, Granger CB, Puma JA, Hellkamp AS, Hochman JS, Ohman EM, White HD, Van de Werf F, Armstrong PW, Ellis SG, Califf RM, Topol EJ. Roe MT, et al. Among authors: topol ej. Am J Cardiol. 2001 Dec 15;88(12):1403-6, A6. doi: 10.1016/s0002-9149(01)02119-1. Am J Cardiol. 2001. PMID: 11741559 No abstract available.
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP, Granger CB, Topol EJ, Pieper KS, Armstrong PW, Barbash GI, Guerci AD, Vahanian A, Califf RM, Ohman EM. Hudson MP, et al. Among authors: topol ej. Circulation. 2001 Sep 11;104(11):1229-35. doi: 10.1161/hc3601.095717. Circulation. 2001. PMID: 11551872
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial.
Al-Khatib SM, Pieper KS, Lee KL, Mahaffey KW, Hochman JS, Pepine CJ, Kopecky SL, Akkerhuis M, Stepinska J, Simoons ML, Topol EJ, Califf RM, Harrington RA. Al-Khatib SM, et al. Among authors: topol ej. Am J Cardiol. 2001 Jul 1;88(1):A7, 76-9. doi: 10.1016/s0002-9149(01)01593-4. Am J Cardiol. 2001. PMID: 11423065 Clinical Trial. No abstract available.
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Van De Werf F, Pfisterer M, Hasselblad V, Califf RM, Topol EJ. Newby LK, et al. Among authors: topol ej. Circulation. 2001 Jun 19;103(24):2891-6. doi: 10.1161/01.cir.103.24.2891. Circulation. 2001. PMID: 11413076 Clinical Trial.
1,184 results